ConductScience.org, home

Paper39770542

Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy.

Mihaylova R and 3 others. Pharmaceuticals (Basel), 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy. Papers, record 39770542. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39770542

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy.
PubMed
Journal
Pharmaceuticals (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.46, provisional
iCite
Revised in PubMed
2025-01-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mihaylova RRositsahttps://orcid.org/0000-0001-5763-0730
2Momekova DDenitsahttps://orcid.org/0000-0001-8112-6761
3Elincheva VViktoria
4Momekov GGeorgihttps://orcid.org/0000-0003-2841-7089

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
project № BG-RRP-2.004-0004-C01European Union's NextGenerationEU economic recovery package via the National Recovery and Resilience Plan of the Republic of BulgariaPubMed

Source PubMed

Download CSV of grants

References235

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138179054Targeting Trop2 in solid tumors: a look into structures and novel epitopes.Front Immunol2023https://conductscience.org/library/papers/38179054PubMed
237218076Novel Anti-HER2 Antibody-Drug Conjugates Versus T-DM1 for HER2-Positive Metastatic Breast Cancer After Tyrosine Kinase Inhibitors Treatment.Oncologist2023https://conductscience.org/library/papers/37218076PubMed
332943087BCMA-targeted immunotherapy for multiple myeloma.J Hematol Oncol2020https://conductscience.org/library/papers/32943087PubMed
432305312An overview on anti-tubulin agents for the treatment of lymphoma patients.Pharmacol Ther2020https://conductscience.org/library/papers/32305312PubMed
538007239Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas.J Immunother Cancer2023https://conductscience.org/library/papers/38007239PubMed
638758596The Evolution of Antibody-Drug Conjugates: Toward Accurate DAR and Multi-specificity.ChemMedChem2024https://conductscience.org/library/papers/38758596PubMed
728138156Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells.Immunol Cell Biol2017https://conductscience.org/library/papers/28138156PubMed
838639400AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody-Drug Conjugate Synthesis.Org Lett2024https://conductscience.org/library/papers/38639400PubMed
920108971Cancer therapies utilizing the camptothecins: a review of the in vivo literature.Mol Pharm2010https://conductscience.org/library/papers/20108971PubMed
1027913999The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer.Cancer Metastasis Rev2016https://conductscience.org/library/papers/27913999PubMed
1138704241Antibody-drug conjugates in solid tumors; new strategy for cancer therapy.Jpn J Clin Oncol2024https://conductscience.org/library/papers/38704241PubMed
1231628266Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia.Oncologist2020https://conductscience.org/library/papers/31628266PubMed
1316990856Topoisomerase I inhibitors: camptothecins and beyond.Nat Rev Cancer2006https://conductscience.org/library/papers/16990856PubMed
1422811920Acute Liver Failure Caused by Amanita phalloides Poisoning.Int J Hepatol2012https://conductscience.org/library/papers/22811920PubMed
1529901160Trop2 is a potential biomarker for the promotion of EMT in human breast cancer.Oncol Rep2018https://conductscience.org/library/papers/29901160PubMed
1637896162Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions.Pharmaceutics2023https://conductscience.org/library/papers/37896162PubMed
1736894324AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody-Drug Conjugate Production.Bioconjug Chem2023https://conductscience.org/library/papers/36894324PubMed
1835094917Emerging roles for folate receptor FOLR1 in signaling and cancer.Trends Endocrinol Metab2022https://conductscience.org/library/papers/35094917PubMed
1923462379Ribosome-inactivating proteins: from toxins to useful proteins.Toxicon2013https://conductscience.org/library/papers/23462379PubMed
2038439551Biparatopic antibodies: therapeutic applications and prospects.MAbs2024https://conductscience.org/library/papers/38439551PubMed

See all 235 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42185658Antibody-drug conjugates in cancer therapy: do we need biomarkers? A comprehensive review.Cancer Metastasis Rev2026https://conductscience.org/library/papers/42185658PubMed
42043624Antibody-Drug Conjugates Reshape the Landscape of Cancer Therapy: Evolution, Challenges and Future Perspectives from the Concept of "Magic Bullet" to Clinical Application.Curr Oncol Rep2026https://conductscience.org/library/papers/42043624PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39770542

GET https://conductscience.org/api/papers/v1/39770542/references?page=2